Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

Meiwu Technology Surges 88% in Premarket After Steep Decline
Markets Daniel Marsh

Meiwu Technology Surges 88% in Premarket After Steep Decline

Meiwu Technology shares rebounded 88% in premarket trading Tuesday after a sharp drop Monday. The company recently raised $15.65 million for an AI skincare platform.

WNW
Standard Chartered to Cut 7,000 Jobs, Target 18% Return by 2030
Markets Daniel Marsh

Standard Chartered to Cut 7,000 Jobs, Target 18% Return by 2030

Standard Chartered announces 7,000 job cuts by 2030, targeting 18% RoTE, as it uses AI and automation to streamline operations. Record Q1 results support the plan.

SAP Shares Surge on AI Optimism and Positive Analyst Ratings
Markets Daniel Marsh

SAP Shares Surge on AI Optimism and Positive Analyst Ratings

SAP SE shares jumped 5.8% on Tuesday, buoyed by AI-related announcements and favorable analyst coverage, though the stock remains down 25% for the year.

SAP DB
Markets Daniel Marsh

AEP's $78B Plan Raises Questions as Institutional Stakes Shift

American Electric Power's $78 billion capital plan highlights rising data center demand, but 13F filings reveal reduced institutional stakes, adding uncertainty.

AEP
Futures Edge Lower as Wall Street Awaits Nvidia Earnings
Markets Daniel Marsh

Futures Edge Lower as Wall Street Awaits Nvidia Earnings

Nasdaq 100 futures fell 0.51% early Tuesday as tech shares pulled back ahead of Nvidia's earnings. Markets are also watching retail earnings from Home Depot and Walmart this week.

NVDA HD WMT SPY QQQ USO GLD
Virax Biolabs Stock Extends Surge on RedChip Promo, Filing
Markets Daniel Marsh

Virax Biolabs Stock Extends Surge on RedChip Promo, Filing

Virax Biolabs shares surged 53.1% Monday and climbed another 17.1% premarket Tuesday, driven by a paid RedChip TV segment and a May 15 ownership filing showing Armistice Capital's 4.99% stake.

VRAX
Amesite Stock Surges on Largest NurseMagic Contract
Markets Daniel Marsh

Amesite Stock Surges on Largest NurseMagic Contract

Amesite Inc. shares surged 218% in premarket trading after securing its largest NurseMagic deployment with a 2,700-patient home-care client, though the company still faces financial uncertainty.

AMST
GeoVax Shares Surge on Biodefense Funding and Ebola Alert
Markets Daniel Marsh

GeoVax Shares Surge on Biodefense Funding and Ebola Alert

GeoVax Labs shares surged nearly 80% after announcing a $3 million private placement, riding a wave of biodefense interest sparked by WHO's Ebola emergency in Africa.

GOVX
Evolution AB Launches €2B Buyback, Shares Surge 9%
Markets Daniel Marsh

Evolution AB Launches €2B Buyback, Shares Surge 9%

Evolution AB shares surged 9% in Stockholm after announcing a €2 billion share buyback, one of Sweden's largest. The program starts immediately and may run until the 2027 annual meeting.

NextEra Energy Slips on $66.8B Dominion Deal; Market Eyes AI Demand
Markets Daniel Marsh

NextEra Energy Slips on $66.8B Dominion Deal; Market Eyes AI Demand

NextEra Energy shares dropped 4.6% after unveiling a $66.8 billion stock merger with Dominion Energy, creating a utility giant serving 10 million customers. The deal targets rising AI data center power demand.

NEE D DUK SO XLU
T1 Energy Shares Jump on Institutional Filing, Solar Plans in Focus
Markets Daniel Marsh

T1 Energy Shares Jump on Institutional Filing, Solar Plans in Focus

T1 Energy shares surged 23% after a regulatory filing showed Situational Awareness LP held 10 million shares. The solar maker's Q1 revenue of $177.6M and on-schedule Austin plant fuel momentum.

Warner Bros. Discovery Stock Trades Below Intrinsic Value Amid Merger Speculation
Markets Daniel Marsh

Warner Bros. Discovery Stock Trades Below Intrinsic Value Amid Merger Speculation

Warner Bros. Discovery shares trade at $27.10, roughly 10% below some intrinsic value estimates but above a cited fair value of $18.17. Analysts remain divided amid merger talks with Paramount and regulatory uncertainty.

WBD